Teleflex Overview
- Year Founded
-
1943

- Status
-
Public
- Employees
-
14,100

- Stock Symbol
-
TFX

- Investments
-
58
- Share Price
-
$111.06
- (As of Friday Closing)
Teleflex General Information
Description
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Contact Information
Website
www.teleflex.comCorporate Office
- 550 East Swedesford Road
- Suite 400
- Wayne, PA 19087
- United States
Corporate Office
- 550 East Swedesford Road
- Suite 400
- Wayne, PA 19087
- United States
Teleflex Timeline
Teleflex Stock Performance
As of 18-Jul-2025, Teleflex’s stock price is $111.06. Its current market cap is $4.91B with 44.2M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$111.06 | $113.59 | $110.83 - $249.91 | $4.91B | 44.2M | 567K | $3.21 |
Teleflex Financials Summary
As of 31-Mar-2025, Teleflex has a trailing 12-month revenue of $3.01B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 7,639,206 | 9,884,180 | 12,985,085 | 13,119,479 |
Revenue | 3,010,144 | 3,047,324 | 2,974,489 | 2,791,041 |
EBITDA | 557,264 | 425,614 | 748,431 | 729,861 |
Net Income | 149,388 | 69,675 | 356,328 | 363,139 |
Total Assets | 7,163,290 | 7,097,914 | 7,532,546 | 6,928,063 |
Total Debt | 2,004,982 | 1,755,025 | 1,926,372 | 1,831,960 |
Teleflex Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Teleflex Comparisons
Industry
Financing
Details
Teleflex Competitors (24)
One of Teleflex’s 24 competitors is Integra Lifesciences, a Corporation company based in Princeton, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Integra Lifesciences | Corporation | Princeton, NJ | ||||
Edwards Lifesciences | Corporation | Irvine, CA | ||||
Boston Scientific | Corporation | Marlborough, MA | ||||
Stryker | Formerly VC-backed | Portage, MI | ||||
Zimmer Biomet Holdings | Corporation | Warsaw, IN |
Teleflex Patents
Teleflex Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250049426-A1 | Vascular closure device with retraction assembly for repositioning a footplate | Pending | 07-Aug-2023 | ||
US-20250049425-A1 | Vascular closure device with retraction element for repositioning a sealing plug | Pending | 07-Aug-2023 | ||
AU-2024208084-A1 | Guide extension catheter | Pending | 12-Jan-2023 | ||
US-20240238555-A1 | Guide extension catheter | Pending | 12-Jan-2023 | ||
US-20240215967-A1 | Bioabsorbable occlusion system | Pending | 03-Jan-2023 | A61B17/0057 |
Teleflex Signals
Teleflex Investments & Acquisitions (58)
Teleflex’s most recent deal was a Merger/Acquisition with Biotronik (Vascular Intervention Business) for . The deal was made on 01-Jul-2025.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Biotronik (Vascular Intervention Business) | 01-Jul-2025 | Merger/Acquisition | Medical Supplies | ||
Palette Life Sciences | 10-Oct-2023 | Merger/Acquisition | Other Devices and Supplies | ||
Standard Bariatrics | 27-Sep-2022 | Merger/Acquisition | Surgical Devices | ||
Traverse Vascular | 13-Jun-2022 | Merger/Acquisition | Therapeutic Devices | ||
QuikClot (Medical Supplies) | 28-Dec-2020 | Merger/Acquisition | Medical Supplies |
Teleflex ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
23.77 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile

Healthcare
Industry
of 562
Rank
Percentile

Medical Devices
Subindustry
of 194
Rank
Percentile

Teleflex Exits (10)
Teleflex’s most recent exit was on 01-Nov-2007 from Nordisk Aviation Products. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Nordisk Aviation Products | 01-Nov-2007 | Completed |
|
||
Southern Wire | 26-Apr-2007 | Completed |
|
||
Kongsberg Automotive Shawinigan | 12-Feb-2003 | Completed |
|
||
Southwest Wire Rope | 13-May-2002 | Completed |
|
||
Triumph Controls-UK | 01-Jan-2001 | Merger/Acquisition | Completed |
Teleflex Affiliates
Subsidiaries (7)
Name | Industry | Location | Year Founded |
---|---|---|---|
Standard Bariatrics | Cincinnati, OH | 2014 | |
TrinTris Medical | Rancho Santa Margarita, CA | 2011 | |
Palette Life Sciences | Stockholm, Sweden | 2009 | |
QuikClot (Medical Supplies) | Boston, MA | 2002 | |
LMA International (Medical Supplies) | Willemstad, Netherlands | 1998 |
Teleflex FAQs
-
When was Teleflex founded?
Teleflex was founded in 1943.
-
Where is Teleflex headquartered?
Teleflex is headquartered in Wayne, PA.
-
What is the size of Teleflex?
Teleflex has 14,100 total employees.
-
What industry is Teleflex in?
Teleflex’s primary industry is Surgical Devices.
-
Is Teleflex a private or public company?
Teleflex is a Public company.
-
What is Teleflex’s stock symbol?
The ticker symbol for Teleflex is TFX.
-
What is the current stock price of Teleflex?
As of 18-Jul-2025 the stock price of Teleflex is $111.06.
-
What is the current market cap of Teleflex?
The current market capitalization of Teleflex is $4.91B.
-
What is Teleflex’s current revenue?
The trailing twelve month revenue for Teleflex is $3.01B.
-
Who are Teleflex’s competitors?
Integra Lifesciences, Edwards Lifesciences, Boston Scientific, Stryker, and Zimmer Biomet Holdings are some of the 24 competitors of Teleflex.
-
What is Teleflex’s annual earnings per share (EPS)?
Teleflex’s EPS for 12 months was $3.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »